Company Filing History:
Years Active: 2004-2014
Title: Inventor Spotlight: Krishnaswamy Narayanan
Introduction
Krishnaswamy Narayanan is a notable inventor based in Waukesha, Wisconsin. With a focus on innovative pharmaceutical solutions, he holds two patents that contribute to advancements in drug delivery systems. His work aims at overcoming challenges associated with poorly water-soluble compounds.
Latest Patents
Krishnaswamy's latest patents detail an innovative process for the preparation of submicron-sized nanoparticles via dispersion lyophilization. This invention involves lyophilizing a dispersion or microdispersion of a multiphase system containing an organic phase and an aqueous phase. The organic phase consists of the poorly water-soluble organic compound, making the nanoparticles suitable for in vivo delivery, particularly through parenteral routes. This innovative approach addresses significant hurdles in pharmaceutical formulations.
Career Highlights
Krishnaswamy currently works for Baxter International Inc., a leading global healthcare company. His contributions in developing effective nanoparticle systems are pivotal for the advancement of medications that require enhanced bioavailability. His innovative methods not only support pharmaceutical development but also improve patient outcomes by facilitating better drug delivery systems.
Collaborations
Throughout his career, Krishnaswamy has collaborated with esteemed colleagues, including Sean Brynjelsen and Mark Joseph Doty. These partnerships underline the collaborative spirit prevalent in research institutions as they work together to push the boundaries of medical science and technology.
Conclusion
Krishnaswamy Narayanan exemplifies the spirit of innovation with his contributions to the field of pharmaceutical technology. His patents focusing on nanoparticle preparation pave the way for future developments in drug delivery systems, ultimately enhancing therapeutic efficacy for patients. His work continues to inspire both peers and future inventors in the ever-evolving landscape of medical breakthroughs.